Riskpilot← Back to searchSign inGet full accessValonne Oy
OYDissolvedY-tunnus 3213732-7Itsenäisyydenkatu 3-A11Retail sale of medical and orthopaedic goods · NACE 4774Est. 2021— employees
Revenue 2025
EUR 0
EBITDA margin
—
-100% vs 2024
Equity ratio
99.5%
Financial strength
Net profit 2025
EUR -596
-106% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR -638 | -100% |
| Net profit | EUR -596 | -106% |
| Total assets | EUR 203K | -8% |
| Equity | EUR 202K | -8% |
| Employees | — | — |
Legal name
Valonne Oy
Y-tunnus number
3213732-7
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
26. toukokuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa, tukkukauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi- ja koulutuspalvelut ja henkilöstövuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen, sekä musiikin tuottaminen, ohjelmapalvelut, julkaiseminen sekä terapia- ja hyvinvointipalvelut.
Address
Itsenäisyydenkatu 3-A11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 454 | 452 | 173 | 0 |
| Staff expenses | 0 | 0 | 0 | −0 |
| EBITDA | 780 | 787 | 332 | −1 |
| Depreciation & amort. | 4 | 3 | 2 | — |
| EBIT | 124 | 115 | 12 | −1 |
| Net financials | −0 | — | — | — |
| Profit before tax | 124 | 115 | 12 | −1 |
| Tax | 25 | 23 | 2 | −0 |
| Net profit | 99 | 91 | 10 | −1 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 172 | 262 | 221 | 203 |
| Equity | 149 | 228 | 220 | 202 |
| Long-term debt | — | — | — | — |
| Short-term debt | 23 | 34 | 1 | 1 |
| Total debt | 23 | 34 | 1 | 1 |
EBITDA margin
-63800.0%
This company
15.8%
Market median
-403897% vs market
20222025
Equity ratio
99.5%
This company
38.2%
Market median
+160% vs market
20222025
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20222025
Net profit margin
-59600.0%
This company
8.1%
Market median
-735902% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SL Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
AE Deputy Member | Deputy Member | 2021 | — | — |
AJ Deputy Member | Deputy Member | 2021 | — | — |
JB Audit | Audit | 2021 | — | — |
TT Deputy auditor | Deputy auditor | 2021 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Valonne Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sirkka Liisa Pihlanne | Chief Executive Officer | 0 companies |
| Aliisa Eveliina Pihlanne | Deputy Member | 0 companies |
| Akseli Johannes Hirvonen | Deputy Member | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |
| Timo Tapio Post | Deputy auditor | 0 companies |